Summary by Moomoo AI
On January 2, 2024, T2 Biosystems, Inc., a company registered in Delaware and listed on The Nasdaq Capital Market under the trading symbol TTOO, announced the immediate resignation of Thierry Bernard from his position as a Class II director. Bernard's resignation, detailed in a written letter, was not due to any disputes or disagreements with the company or its management but was attributed to other personal commitments. Bernard was a member of the company's Audit Committee prior to his departure. The Audit Committee will continue with David Elsbree as Chairman, alongside members Ninfa Saunders and Seymour Liebman.